• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these drugs can affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the benefits of taking them against potential risks to the foetus. Doctors don't have enough data to give clear advice however they can you get adhd medication without a diagnosis uk provide information on risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major structural birth defects. Researchers used a large sample-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who used stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to make sure that the classification was correct and to reduce any bias.

The research conducted by the researchers was not without its limitations. The researchers were not able, in the first place, to separate the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to determine if the few associations observed between the groups exposed were due to medication use, or if they were confounded by co-morbidities. The researchers also did not look at long-term outcomes for offspring.

The study did find that babies whose mothers had taken ADHD medication during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had stopped their medications before or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who used stimulant ADHD medication for odd and adhd during pregnancy were also at an increased risk of having a caesarean birth or having a baby with a low Apgar score (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during early pregnancy could be offset by the higher benefit to both mother and child of continued treatment for the woman's disorder. Physicians should discuss this with their patients and, if they are able, assist them in developing strategies for improving their coping skills that can lessen the effects of her disorder on her daily functioning and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to continue treatment or by botdb.win stop as more women are diagnosed with ADHD. The majority of these decisions are made in the absence of clear and authoritative evidence in either case, sunriji.com which means that doctors must weigh what they know about their experiences, the experiences of other doctors, and what research suggests about the subject and their own best adhd medication for women judgment for each patient.

Particularly, the issue of potential risks to the infant can be difficult. A lot of studies on this subject are based on observations instead of controlled research and their findings are often contradictory. Most studies restrict their analysis to live births, which can underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study that is discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion The conclusion: While some studies have shown a positive association between ADHD medications and the possibility of certain birth defects, others have found no connection, and most studies demonstrate a neutral or slightly negative impact. In each case an in-depth analysis of the benefits and risks is required.

For many women with ADHD and ADD, the decision to stop medication is difficult, if not impossible. In a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness and family conflict for those suffering from the disorder. Furthermore, a loss of medication can affect the ability to complete job-related tasks and drive safely that are crucial aspects of daily life for many people with adhd medication Pregnancy.

She suggests that women who are unsure about whether to continue or discontinue medication due to their pregnancy consider informing family members, friends and colleagues on the condition, its effects on daily functioning, and the benefits of keeping the current treatment plan. In addition, educating them can help the woman feel supported when she is struggling with her decision. It is important to note that certain medications are able to be absorbed through the placenta therefore, if a patient decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug can be transferred to the child.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about the effects that the medications could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Researchers utilized two massive data sets to examine more than 4.3 million pregnant women and determine whether stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to ADHD medications was linked to an increase in the risk of certain heart defects such as ventriculoseptal defect (VSD).

The researchers of the study could not discover any link between the use of early medications and congenital anomalies such as facial deformities or club feet. The results are in line with previous studies which showed an insignificant, but small increase in the number of cardiac malformations among women who started taking ADHD medication prior to the birth of their child. This risk increased during the latter part of pregnancy, when many women are forced to stop taking their medication.

Women who took ADHD medication in the first trimester were more likely to require a caesarean delivery and also have a low Apgar after birth and have a baby that needed breathing assistance at birth. However the researchers of the study were not able to eliminate bias due to selection by limiting the study to women who did not have other medical issues that could have contributed to these findings.

Researchers hope that their research will provide doctors with information when they encounter pregnant women. They suggest that although a discussion of the benefits and risks is important, the decision to stop or maintain medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also caution that while discontinuing the medications is an alternative, it is not an option to consider due to the high incidence of depression and other mental health issues among women who are pregnant or who are recently post-partum. Further, the research suggests that women who choose to stop taking their medications are more likely to have a difficult time adapting to life without them following the baby's arrival.

Nursing

It can be a stressful experience becoming a mother. Women with ADHD who have to deal with their symptoms while attending physician appointments and preparing for the arrival of a child and adapting to new routines in the home may face a lot of challenges. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in small amounts, so the risk for nursing infant is very low. However, the amount of exposure to medication by the infant can differ based on dosage, frequency it is taken and the time of the day the medication is administered. Additionally, different medications enter the body of the baby differently through the gastrointestinal tract and breast milk. The impact of this on a newborn is not yet fully understood.

Because of the lack of evidence, some doctors might be tempted to stop taking stimulant medications during a woman's pregnancy. This is a difficult choice for the patient, who must weigh the benefits of continuing her medication with the potential dangers to the fetus. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are taking or planning to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue to take their ADHD medication safely during pregnancy and breast-feeding. This has led to an increasing number of patients are choosing to do so and in consultation with their physician, they have discovered that the benefits of keeping their current medication outweigh any potential risks.

Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD understand their symptoms and the root cause and learn about treatment options and strengthen existing strategies for coping. This should be a multidisciplinary approach together with obstetricians, GPs and psychiatrists. Counselling for pregnancy should include the discussion of a treatment plan for both the mother and child, and monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.